GB Sciences, Inc. Announces the Arrival of the First GrowBLOX(TM) Cultivation Chamber in Las Vegas, Nevada

        Print
| Source: GrowBlox Sciences Inc

LAS VEGAS, Aug. 11, 2014 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced today that the first GrowBLOX™ cultivation chamber has arrived in Las Vegas, Nevada. With the arrival of The Company's core technology, GB Sciences will be better prepared to commence its cultivation operations in Nevada; pending the upcoming Nevada State Licensing decision. Through its local, majority-owned subsidiary, GB Sciences Nevada, LLC, GB Sciences, Inc. is awaiting final license approval for one cultivation facility in Clark County, Nevada, and three medical marijuana dispensaries, two in the City of Las Vegas and one in Clark County, Nevada. GB Sciences has already received special use permits for one dispensary and one cultivation facility issued by the Clark County Commissioner's Office. The State is expected to make their decisions as early as this month, but no later than November 3, 2014.

Chief Science Officer Andrea Small-Howard, PhD, MBA, said, "Having our cutting-edge GrowBLOX™ chamber here is very exciting because it represents one important step towards completing our vision of a complete, proprietary GrowBLOX™ Cultivation Solution. We are completing the development of a series of GrowBLOX™ chambers, which are uniquely designed for: a) sterile tissue culture (propagation); b) medical-grade marijuana cultivation (core GrowBLOX™ chamber); c) curing and drying processes; and d) proprietary cannabinoid extraction methodologies. Our GrowBLOX™ Cultivation Solutions will allow us to consistently grow toxin-free medical marijuana of the highest efficacy from harvest to harvest; then process the resulting marijuana using our proprietary cannabinoid extraction procedures. In the near future, these cannabinoid-containing extracts will ultimately be used in the production of a pharmaceutical product line."

The Company will be posting images of the GrowBLOX™ along with a webcam feed of the growth process inside the cultivation chamber on their corporate website: www.gbsciences.com

About GrowBLOX Sciences, Inc.

GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Jonathan Barkman
Riverview Capital Enterprises
+1-866-845-0105